Novel Phenicol Derivatives Overcoming Bacterial Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antibiotic agents that can effectively treat bacterial infections in animals, particularly those resistant to existing antibiotics like florfenicol, which is facing increasing resistance across multiple bacterial genera and species.
Innovation Solution
Development of novel phenicol derivatives, specifically compounds of formulas I, II, III, and IV, which are used in pharmaceutical compositions for treating bacterial infections, including bovine respiratory disease, by administering a therapeutically effective amount to mammals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If florfenicol is used to treat bacterial infections, then broad spectrum activity against gram-negative and gram-positive bacteria is achieved, but bacterial resistance develops across multiple genera and species
Solution Approach 1:
The patent modifies the chemical structure of florfenicol by replacing the phenolic hydroxyl group with various substituted phenyl groups (such as halogenated, alkylated, or heteroatom-substituted phenyl groups) and modifying the side chain at the 3-position. These structural parameter changes create novel phenicol derivatives that maintain activity against florfenicol-resistant bacteria while preserving the core mechanism of action on bacterial protein synthesis
Solution Approach 2:
The invention combines the core florfenicol structure with various substituent groups to create composite molecular structures. The resulting compounds integrate the beneficial properties of the original phenicol scaffold with additional functional groups that enhance activity against resistant strains, effectively creating a new generation of phenicol antibiotics
2Reliability
If new antibiotic agents are developed to overcome resistance, then activity against resistant pathogens is improved, but the complexity of antibiotic development and regulatory approval increases
Solution Approach 1:
The patent systematically divides the florfenicol molecule into modifiable segments: the core phenolic ring, the side chain at position 3, and the amino group at position 4. By independently modifying these segments with various substituents, the invention creates a library of derivatives that can be screened for activity against resistant pathogens, thereby managing development complexity through structured molecular design
Solution Approach 2:
The core phenicol structure is preserved across all derivatives to maintain the universal mechanism of action on bacterial protein synthesis. This universal scaffold allows multiple substituted variants to be developed simultaneously, each targeting different resistance mechanisms while sharing the same fundamental mode of action, thereby streamlining the development process
Data Source
AI summary
The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical compositions containing these novel compounds, and methods for the preparation of these compounds.